Assets, Current of RayzeBio, Inc. from 31 Dec 2022 to 30 Sep 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: RayzeBio, Inc. quarterly Assets, Current in USD history and change rate from 31 Dec 2022 to 30 Sep 2023.
RayzeBio, Inc. Assets, Current for the quarter ending 30 Sep 2023 was $544,986,000.
Source SEC data: View on sec.gov

Assets, Current, Quarterly (USD)

RayzeBio, Inc. Quarterly Assets, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2023	$544,986,000			30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q4 2022	$300,037,000			31 Dec 2022	10-Q	13 Nov 2023	2023	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.